Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin

Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm

Koppers Announces Conditional Plan to Discontinue Production Activities at Facility in Stickney, Illinois

Fifth Third Bancorp Commences Private Exchange Offers and Fifth Third Financial Corporation Commences Consent Solicitations

MicroAlgo Inc. Develops Quantum Architecture Search (QAS) Technology to Enhance VQA Robustness and Trainability, Optimizing the Potential of Quantum Computing Devices

Niagen Bioscience Announces Participation in Upcoming Investor Conferences

ITAÚ UNIBANCO - Material Fact: News Portal Change

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung

Day One and Servier Complete Enrollment in Pivotal Phase 3 FIREFLY-2 Trial of Tovorafenib as a Front-Line Treatment for Pediatric Low-Grade Glioma (pLGG)

Arbor Realty Trust Reports First Quarter 2026 Results and Declares Dividend of $0.17 per Share

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

Skycorp to Hold Extraordinary General Meeting

Timken Raises Quarterly Dividend to 36 Cents Per Share; Marking 13 Years of Increases

Global Payments Expands Partnership with Lightspeed DMS to Power Embedded Payments for Dealerships

Stran & Company Schedules First Quarter 2026 Financial Results and Business Update Conference Call

Netcapital Inc. Announces Strategic Shift

Rush Street Interactive to Participate at the 21st Annual Needham Technology, Media, & Consumer Conference

Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference

First Court Hearing Results & Scheme Booklet ASIC Registered

Atossa Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update